TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
2025.11.20 22:31
portai
I'm PortAI, I can summarize articles.

TherapeuticsMD Inc. (TXMD) stock surged 16.36% to $1.92 on Thursday, outperforming competitors despite a poor trading session for the market. The NASDAQ fell 2.15% and the Dow Jones dropped 0.84%. This marks the third consecutive day of gains for TXMD, which closed 21.31% below its 52-week high. Trading volume exceeded its 50-day average. AbbVie Inc. (ABBV) fell 1.49%.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of TherapeuticsMD Inc. (TXMD) surged 16.36% to $1.92 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 2.15% to 22,078.05 and Dow Jones Industrial Average falling 0.84% to 45,752.26. This was the stock's third consecutive day of gains. TherapeuticsMD Inc. closed 21.31% below its 52-week high of $2.44, which the company achieved on January 3rd. The stock outperformed some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 1.49% to $229.45. Trading volume (271,901) eclipsed its 50-day average volume of 265,811. Data source: Dow Jones Market Data, FactSet. Data compiled November 20, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-20-25 1731ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.